KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Invested Capital (2016 - 2025)

Historic Invested Capital for Teva Pharmaceutical Industries (TEVA) over the last 17 years, with Q4 2025 value amounting to $9.7 billion.

  • Teva Pharmaceutical Industries' Invested Capital rose 3593.07% to $9.7 billion in Q4 2025 from the same period last year, while for Dec 2025 it was $9.7 billion, marking a year-over-year increase of 3593.07%. This contributed to the annual value of $9.7 billion for FY2025, which is 3593.07% up from last year.
  • Latest data reveals that Teva Pharmaceutical Industries reported Invested Capital of $9.7 billion as of Q4 2025, which was up 3593.07% from $7.3 billion recorded in Q3 2025.
  • In the past 5 years, Teva Pharmaceutical Industries' Invested Capital ranged from a high of $14.8 billion in Q2 2021 and a low of $6.7 billion during Q1 2025
  • Its 5-year average for Invested Capital is $10.3 billion, with a median of $9.8 billion in 2023.
  • Within the past 5 years, the most significant YoY rise in Teva Pharmaceutical Industries' Invested Capital was 3593.07% (2025), while the steepest drop was 3690.46% (2025).
  • Quarter analysis of 5 years shows Teva Pharmaceutical Industries' Invested Capital stood at $12.7 billion in 2021, then fell by 15.49% to $10.7 billion in 2022, then fell by 8.49% to $9.8 billion in 2023, then dropped by 26.91% to $7.2 billion in 2024, then surged by 35.93% to $9.7 billion in 2025.
  • Its last three reported values are $9.7 billion in Q4 2025, $7.3 billion for Q3 2025, and $7.3 billion during Q2 2025.